Align Technology, Inc. (ALGN) vs ImmunityBio, Inc. (IBRX)

A side-by-side comparison of Align Technology, Inc. and ImmunityBio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALGN vs IBRX

growth of $100 · dividends reinvested · last 10y
ALGN +52.2% (+4.3%/yr)IBRX +41.8% (+3.6%/yr)ALGN compounded faster over this window
0200400600800Start $10020182020202220242026$152$142
ALGN IBRX

ALGN vs IBRX: by the numbers

  • •IBRX is the larger company ($10.15B vs $10.13B market cap).
  • •ALGN is profitable (9.99% net margin) while IBRX runs a net loss (-598.56%).
  • •IBRX grew revenue faster over the past five years (202.97% vs 3.57% CAGR).

Metrics side by side

Valuation

MetricALGNIBRX
P/E ratio24.56N/A
Forward P/E12.55N/A
P/S ratio2.4561.21
P/B ratio2.39N/A
EV / EBITDA11.35N/A

Profitability

MetricALGNIBRX
Gross margin66.48%94.63%
Operating margin13.33%-226.00%
Net margin9.99%-598.56%
ROE9.77%N/A
ROIC8.90%-45.63%

Growth (annualized)

MetricALGNIBRX
Revenue CAGR (5Y)3.57%202.97%
EPS CAGR (5Y)-24.16%N/A
Total return CAGR (5Y)-26.34%0.39%

Some values include inputs from SEC filing.

Frequently asked

Which has grown faster, ALGN or IBRX?
Over the past five years, IBRX grew revenue faster — ALGN at a 3.57% CAGR versus IBRX at 202.97%.
Is ALGN or IBRX more profitable?
ALGN runs the higher net margin — ALGN at 9.99% versus IBRX at -598.56%.
How have ALGN and IBRX total returns compared?
Over the past 10 years, ALGN delivered 4.63% and IBRX delivered 2.95% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.